Cryoport (NASDAQ: CYRX) reported Q4 EPS of ($0.26), $0.24 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $1.7 million.

The Company reported $2.8 million in cash and cash equivalents as of March 31, 2016, compared to $1.4 million as of fiscal year ended March 31, 2015.

For earnings history and earnings-related data on Cryoport (CYRX) click here.